Literature DB >> 28864359

Hepatitis E in Italy: A silent presence.

Carlo Mauceri1, Maria Grazia Clemente2, Paolo Castiglia3, Roberto Antonucci4, Kathleen B Schwarz5.   

Abstract

Hepatitis E virus (HEV) was discovered in the 1980s and has been considered as being confined to developing countries. The purpose of this critical review was to determine the reported HEV seroprevalence rates in Italy, to identify predisposing factors and individuals at risk and to assess possible importation of HEV by immigrants. A critical review of 159 articles published in PubMed from 1994 to date was done. Only 27 original reports of 50 or more subjects, written in the English or Italian language, were included. Over three decades, the HEV seroprevalence varied from 0.12% to 49%, with the highest rates being reported from the central region of Italy. Risk factors included ingestion of raw pork or potentially contaminated food. The seroprevalence among immigrants ranged from 15.3% to 19.7% in Apulia. Italy has a population of 60656000; the total number of individuals surveyed was only 21.882 (0.036%). A national epidemiological survey program is needed to capture more comprehensive seroprevalence data.
Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Epidemiology; Hepatitis E infection; Immigrants; Italy; Risk factors; Seroprevalence

Mesh:

Year:  2017        PMID: 28864359     DOI: 10.1016/j.jiph.2017.08.004

Source DB:  PubMed          Journal:  J Infect Public Health        ISSN: 1876-0341            Impact factor:   3.718


  6 in total

Review 1.  Blood Donor Screening for Hepatitis E Virus in the European Union.

Authors:  Fiona Boland; Auxiliadora Martinez; Louise Pomeroy; Niamh O'Flaherty
Journal:  Transfus Med Hemother       Date:  2019-03-14       Impact factor: 3.747

Review 2.  Hepatitis E Virus and rheumatic diseases: what do rheumatologists need to know?

Authors:  Salvatore Di Bartolomeo; Francesco Carubbi; Paola Cipriani
Journal:  BMC Rheumatol       Date:  2020-09-21

3.  Systematic review and meta-analysis of the seroprevalence of hepatitis E virus in the general population across non-endemic countries.

Authors:  Barbara Wilhelm; Lisa Waddell; Judy Greig; Ian Young
Journal:  PLoS One       Date:  2019-06-07       Impact factor: 3.240

4.  A Special Risk Group for Hepatitis E Infection: The First Record of North Cyprus.

Authors:  Kaya Süer; Meryem Güvenir; Asli Aykaç
Journal:  Pol J Microbiol       Date:  2018

5.  Hepatitis E infection in a patient with rheumatoid arthritis treated with leflunomide: A case report with emphasis on geoepidemiology.

Authors:  Francesco Carubbi; Giovanna Picchi; Salvatore Di Bartolomeo; Alessandra Ricciardi; Paola Cipriani; Laura Marola; Alessandro Grimaldi; Roberto Giacomelli
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

6.  The prevalence of HEV among non-A-C hepatitis in Qatar and efficiency of serological markers for the diagnosis of hepatitis E.

Authors:  Enas S Al Absi; Duaa W Al-Sadeq; Makiyeh Khalili; Nadin Younes; Nader Al-Dewik; Sara K Abdelghany; Somaia S Abouzid; Asma A Al Thani; Hadi M Yassine; Peter V Coyle; Gheyath K Nasrallah
Journal:  BMC Gastroenterol       Date:  2021-06-15       Impact factor: 3.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.